Meriyani, H. et al. (2025) “Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review”, Borneo Journal of Pharmacy, 8(1), pp. 33–48. doi:10.33084/bjop.v8i1.7913.